Titre (en)
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Stress et Covid - Checkpoint (Istex)

Index « Titre (en) » - entrée « potential »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
potent < potential < potentials  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000168 (2015) Ahmed R. El-Awady ; Roger M. Arce ; Christopher W. CutlerDendritic cells: microbial clearance via autophagy and potential immunobiological consequences for periodontal disease
000279 (2013) C. Stevinson [Royaume-Uni] ; J. Kim [Corée du Sud]Potential for qigong as a stress‐management approach
000336 (2013) Eduardo Luis Konrath [Brésil] ; Carolina Dos Santos Passos [Brésil] ; Luiz Carlos Klein-Júnior [Brésil] ; Amélia T. Henriques [Brésil]Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
000462 (2012) Jerica Saboti [Slovénie] ; Janko Kos [Slovénie]Microbial and fungal protease inhibitors—current and potential applications
000485 (2012) Stephen C. Stearns [Allemagne, États-Unis]Evolutionary medicine: its scope, interest and potential
000559 (2011) Danylo Kaminskyy [Ukraine] ; Barbara Bednarczyk-Cwynar [Pologne] ; Olexandr Vasylenko [Ukraine] ; Oxana Kazakova [Russie] ; Borys Zimenkovsky [Ukraine] ; Lucjusz Zaprutko [Pologne] ; Roman Lesyk [Ukraine, Niger]Synthesis of new potential anticancer agents based on 4-thiazolidinone and oleanane scaffolds
000764 (2010) Xiaoling Wang [États-Unis] ; Satish K. Singh [États-Unis] ; Sandeep Kumar [États-Unis]Potential Aggregation-Prone Regions in Complementarity-Determining Regions of Antibodies and Their Contribution Towards Antigen Recognition: A Computational Analysis
000A06 (2009) Gabriele Neumann [États-Unis] ; Takeshi Noda ; Yoshihiro Kawaoka [États-Unis, Japon]Emergence and pandemic potential of swine-origin H1N1 influenza virus
000B22 (2008) Fokke G. Terpstra [Pays-Bas] ; Angélique B. Van T Wout [Pays-Bas] ; Hanneke Schuitemaker [Pays-Bas] ; Frank A. C. Van Engelenburg [Pays-Bas] ; David W. C. Dekkers [Pays-Bas] ; Robin Verhaar [Pays-Bas] ; Dirk De Korte [Pays-Bas] ; Arthur J. Verhoeven [Pays-Bas]Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates
000C65 (2007) Carole Lalonde [Canada]The Potential Contribution of the Field of Organizational Development to Crisis Management
000D29 (2007) Anna M. Likos [États-Unis] ; David J. Kelvin [États-Unis] ; Cheryl M. Cameron [États-Unis] ; Thomas Rowe [États-Unis] ; Matthew J. Kuehnert [États-Unis] ; Philip J. Norris [États-Unis]Influenza viremia and the potential for blood‐borne transmission
000D65 (2007) Peter M. Fischer [Royaume-Uni]Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: Progress 2001–2006
000E72 (2006) Eugene D. Weinberg [États-Unis]Therapeutic potential of iron chelators in diseases associated with iron mismanagement
000E73 (2006) Arthur M. Krieg [États-Unis]Therapeutic potential of Toll-like receptor 9 activation
001227 (2004) Rhidian A. Hughes [Royaume-Uni] ; Anu Sinha [Royaume-Uni] ; Fiona Aspinal [Royaume-Uni] ; Maria Dunckley [Royaume-Uni] ; Julia Addingtonhall [Royaume-Uni] ; Irene J. Higginson [Royaume-Uni]What is the potential for the use of clinical outcome measures to be computerised Findings from a qualitative research study
001576 (2002) Claudia Zuany-Amorim [Royaume-Uni] ; John Hastewell [Royaume-Uni] ; Christoph Walker [Royaume-Uni]Toll-like receptors as potential therapeutic targets for multiple diseases
001618 (2002) Richard Dodel [Allemagne, États-Unis] ; Harald Hampel [Allemagne] ; Candan Depboylu [Allemagne] ; Suizhen Lin [États-Unis] ; Feng Gao [États-Unis] ; Sabine Schock [Allemagne] ; Steffi J Ckel [Allemagne] ; Xing Wei [États-Unis] ; Katharina Buerger [Allemagne] ; Christine Höft [Allemagne] ; Bernhard Hemmer [Allemagne] ; Hans-Jürgen Möller [Allemagne] ; Martin Farlow [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; Norbert Sommer [Allemagne] ; Yansheng Du [États-Unis]Human antibodies against amyloid β peptide: A potential treatment for Alzheimer's disease
001657 (2002) James W. Treasurer [Royaume-Uni]A review of potential pathogens of sea lice and the application of cleaner fish in biological control
001C26 (1993) R. F. Willes [Canada] ; E. R. Nestmann [Canada] ; P. A. Miller [Canada] ; J. C. Orr [Canada] ; I. C. Munro [Canada]Scientific Principles for Evaluating the Potential for Adverse Effects from Chlorinated Organic Chemicals in the Environment
001E39 (1988) M. K. S. Irwin [Royaume-Uni]Interferon, a potential similimum to postviral fatigue syndrome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "potential" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "potential" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    potential
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021